Download MendeleyDesign, synthesis, X-ray studies, and biological evaluation of novel macrocyclic HIV-1 protease inhibitors involving the P1'-P2' ligands.
Ghosh, A.K., Sean Fyvie, W., Brindisi, M., Steffey, M., Agniswamy, J., Wang, Y.F., Aoki, M., Amano, M., Weber, I.T., Mitsuya, H.(2017) Bioorg Med Chem Lett 27: 4925-4931
- PubMed: 28958624
- DOI: https://doi.org/10.1016/j.bmcl.2017.09.003
- Primary Citation of Related Structures:
5WLO - PubMed Abstract:
Design, synthesis, and evaluation of a new class of HIV-1 protease inhibitors containing diverse flexible macrocyclic P1'-P2' tethers are reported. Inhibitor 5a with a pyrrolidinone-derived macrocycle exhibited favorable enzyme inhibitory and antiviral activity (K i =13.2nM, IC 50 =22nM). Further incorporation of heteroatoms in the macrocyclic skeleton provided macrocyclic inhibitors 5m and 5o. These compounds showed excellent HIV-1 protease inhibitory (K i =62pM and 14pM, respectively) and antiviral activity (IC 50 =5.3nM and 2.0nM, respectively). Inhibitor 5o also remained highly potent against a DRV-resistant HIV-1 variant.
Organizational Affiliation:
Department of Chemistry, Purdue University, West Lafayette, IN 47907, USA; Department of Medicinal Chemistry, Purdue University, West Lafayette, IN 47907, USA. Electronic address: akghosh@purdue.edu.
